First Eagle Investment Management’s Cardiff Oncology CRDF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-5,224
Closed -$2.03M 340
2015
Q4
$2.03M Buy
+5,224
New +$2.05M 0.01% 199

Other funds holding CRDF

First Eagle Investment Management's CRDF Position: Q1 2016 in Review

First Eagle Investment Management sold out of Cardiff Oncology (CRDF) in Q1 2016, closing a stake of 5,224 shares — an estimated $2.03M sold.

First Eagle Investment Management first reported a position in CRDF in Q4 2015 and held it in 1 quarter. The position peaked at $2.03M in Q4 2015. 58 funds tracked by Wall St. Rank hold CRDF as of Q1 2016.

  • First Eagle Investment Management reported no remaining Cardiff Oncology position as of Q1 2016 after selling out during the quarter.
  • First Eagle Investment Management sold 5,224 Cardiff Oncology shares in Q1 2016, an estimated $2.03M.
  • First Eagle Investment Management first reported a position in Cardiff Oncology in Q4 2015 and held it in 1 quarter.
  • First Eagle Investment Management's Cardiff Oncology position peaked at $2.03M in Q4 2015.
  • 58 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2016.

Based on First Eagle Investment Management's 13F filing for Q1 2016, filed 5 May 2016.